Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:EDT TSE:HLS NYSEARCA:IDX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDTSpectral MedicalC$1.70C$1.10C$0.46▼C$1.84C$485.89M0.24643798,529 shs156,165 shsHLSHLS TherapeuticsC$5.59-1.9%C$5.13C$3.00▼C$5.75C$175.49M0.65083912,731 shs5,509 shsIDXVanEck Indonesia Index ETF$15.96+1.5%$15.56$10.93▼$19.10$37.51M0.8228,112 shs7,524 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDTSpectral Medical0.00%+4.29%+55.96%+93.18%+161.54%HLSHLS Therapeutics0.00%+2.57%+9.82%+14.08%+66.87%IDXVanEck Indonesia Index ETF0.00%-0.25%-2.62%+6.76%-12.98%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEDTSpectral MedicalC$1.70C$1.10C$0.46▼C$1.84C$485.89M0.24643798,529 shs156,165 shsHLSHLS TherapeuticsC$5.59-1.9%C$5.13C$3.00▼C$5.75C$175.49M0.65083912,731 shs5,509 shsIDXVanEck Indonesia Index ETF$15.96+1.5%$15.56$10.93▼$19.10$37.51M0.8228,112 shs7,524 shsElon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEDTSpectral Medical0.00%+4.29%+55.96%+93.18%+161.54%HLSHLS Therapeutics0.00%+2.57%+9.82%+14.08%+66.87%IDXVanEck Indonesia Index ETF0.00%-0.25%-2.62%+6.76%-12.98%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEDTSpectral Medical 0.00N/AN/AN/AHLSHLS Therapeutics 2.00HoldC$5.00-10.55% DownsideIDXVanEck Indonesia Index ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IDX, HLS, ACL, and EDT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/21/2025HLSHLS TherapeuticsRaymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Moderate BuyC$5.00 ➝ C$6.00(Data available from 9/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEDTSpectral MedicalC$2.53M191.90C$0.02 per share82.50C($0.08) per share-21.25HLSHLS TherapeuticsC$56.42M3.11C$0.37 per share15.22C$2.51 per share2.22IDXVanEck Indonesia Index ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEDTSpectral Medical-C$18.68M-C$0.07N/A∞N/AN/A-973.97%-93.22%N/AHLSHLS Therapeutics-C$15.53M-C$0.48N/A∞N/A-38.70%-25.27%-2.89%N/AIDXVanEck Indonesia Index ETFN/AN/A11.41∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEDTSpectral MedicalN/A1.45%N/AN/AN/AHLSHLS TherapeuticsN/A4.30%N/AN/AN/AIDXVanEck Indonesia Index ETF$0.593.70%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEDTSpectral Medical26.030.610.45HLSHLS Therapeutics86.501.561.01IDXVanEck Indonesia Index ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEDTSpectral Medical0.03%HLSHLS Therapeutics0.42%IDXVanEck Indonesia Index ETFN/AInsider OwnershipCompanyInsider OwnershipEDTSpectral Medical18.18%HLSHLS Therapeutics0.37%IDXVanEck Indonesia Index ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEDTSpectral Medical29285.82 millionN/ANot OptionableHLSHLS Therapeutics9131.39 millionN/ANot OptionableIDXVanEck Indonesia Index ETFN/A2.35 millionN/ANot OptionableIDX, HLS, ACL, and EDT HeadlinesRecent News About These CompaniesIndonesia looks to buy more US wheat in bid for trade dealJuly 7, 2025 | msn.comVanEck submits Onchain Economy ETF application to the SECJanuary 15, 2025 | msn.comTrading (IDX) With Integrated Risk ControlsJanuary 5, 2025 | news.stocktradersdaily.comNVanEck Indonesia Index ETF declares annual distribution of $0.5930December 27, 2024 | msn.comTrend Tracker for (IDX)December 26, 2024 | news.stocktradersdaily.comN(IDX) Investment Analysis and AdviceDecember 15, 2024 | news.stocktradersdaily.comNWhen the Price of (IDX) Talks, People ListenDecember 4, 2024 | news.stocktradersdaily.comNHow to Take Advantage of moves in (IDX)November 23, 2024 | news.stocktradersdaily.comNIndonesia stocks lower at close of trade; IDX Composite Index down 0.88%November 14, 2024 | msn.comIndonesia stocks higher at close of trade; IDX Composite Index up 0.13%November 6, 2024 | msn.comIndonesia stocks lower at close of trade; IDX Composite Index down 1.13%November 6, 2024 | msn.comIDX VanEck Indonesia Index ETFNovember 1, 2024 | seekingalpha.comIndonesia stocks lower at close of trade; IDX Composite Index down 0.92%November 1, 2024 | msn.comIndonesia stocks lower at close of trade; IDX Composite Index down 0.64%October 30, 2024 | msn.comIndonesia stocks lower at close of trade; IDX Composite Index down 0.38%October 30, 2024 | msn.comIndonesia stocks lower at close of trade; IDX Composite Index down 0.98%October 28, 2024 | msn.comIndonesia stocks lower at close of trade; IDX Composite Index down 0.46%October 25, 2024 | msn.comIndonesia stocks lower at close of trade; IDX Composite Index down 0.19%October 25, 2024 | msn.comIndonesia stocks lower at close of trade; IDX Composite Index down 0.12%October 24, 2024 | msn.comIndonesia stocks higher at close of trade; IDX Composite Index up 0.14%October 22, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025Improving Fundamentals Drive New Buybacks for 3 Strong PerformersBy Leo Miller | August 29, 2025Oracle Has Spoken: AI Changes EverythingBy Thomas Hughes | September 10, 2025Spire Global: Tiny Satellites, Big Buy Ratings and UpsideBy Nathan Reiff | September 6, 2025IDX, HLS, ACL, and EDT Company DescriptionsSpectral Medical TSE:EDTC$1.70 0.00 (0.00%) As of 09/12/2025 04:00 PM EasternSpectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation. The segments of the group are Spectral Medical Inc, which is the key revenue-generating segment that manufactures and sells its EAA diagnostic and certain proprietary reagents; Dialco Medical Inc segment; and Corporate.HLS Therapeutics TSE:HLSC$5.59 -0.11 (-1.93%) As of 09/12/2025 03:59 PM EasternHLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.VanEck Indonesia Index ETF NYSEARCA:IDX$15.96 +0.24 (+1.53%) Closing price 09/12/2025 04:10 PM EasternExtended Trading$15.53 -0.43 (-2.72%) As of 09/12/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Market Vectors Indonesia Index ETF (IDX) seeks, before fees and expenses, the price and yield performance of the Market Vectors Indonesia Index (the Index). The Index provides exposure to publicly traded companies that are domiciled and primarily listed in Indonesia, or that generate at least 50% of their revenues in Indonesia. The Index is the property of Market Vectors Index Solutions GmbH, which has contracted with Structured Solutions AG to maintain and calculate the Index. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
